MR CLEAN-MED is a Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands investigating the effect of periprocedural MEDication: heparin, antiplatelet agents, both or neither.

MR CLEAN-MED is one of the 5 randomized trials that will be conducted by the Collaboration for New Treatments of Acute Stroke (CONTRAST) consortium. This trial is designed to answer the question if periprocedural administration of antithrombotic drugs can further improve the beneficial effect of acute endovascular thrombectomy for ischemic stroke.

Kind regards,

On behalf of the MR CLEAN-MED executive committee:

Diederik Dippel, Aad van der Lugt, Rob van de Graaf, Bob Roozenbeek, Adriaan van Es, Heleen den Hertog, Julie Staals, Sjoerd Jenniskens, Lukas van Dijk